Adicet Bio, Inc. (ACET), a company focused on allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, said on Wednesday that it has appointed Julie Maltzman as Chief Medical Officer with effect from January 13, 2025.
She will succeed Francesco Galimi, who has completed his tenure at Adicet this month.
Maltzman joins Adicet from IconOVir Bio, where she served as Chief Medical Officer.
Earlier, she worked as the VP, Global Head of GI Cancers and Cancer Immunotherapy at Roche/Genentech.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.